A ketogenic diet can improve some heart-related markers while worsening others, and the biggest source of concern is a substantial rise in LDL cholesterol or ApoB. Many people see lower triglycerides, higher HDL cholesterol, better blood sugar, and weight loss when carbohydrates are sharply restricted. Those changes can be useful, especially when excess weight, insulin resistance, or high triglycerides are part of the picture. But keto is not automatically “heart healthy.” In randomized trials, average LDL cholesterol often rises, and a smaller group of people develops very large LDL increases. The type of fat you eat, your baseline metabolic health, genetics, weight change, and how strictly you restrict carbohydrates all affect the response. The safest way to judge the diet is not by ketone levels or weight loss alone. It is by looking at your full cardiovascular risk profile, repeating blood tests after the diet has stabilized, and acting promptly if atherogenic cholesterol markers climb sharply.
Table of Contents
- How Keto Changes Blood Lipids
- Why LDL Can Rise on Keto
- Triglycerides, HDL, and Metabolic Changes
- What Makes a Keto Diet More or Less Heart-Friendly
- What to Test and When
- Red Flags That Need Action
- How to Lower Risk Without Abandoning Every Low-Carb Goal
How Keto Changes Blood Lipids
A ketogenic diet usually limits carbohydrate enough to keep the body producing ketones, often to roughly 20–50 g of carbohydrate per day. That shifts fuel use toward fatty acids and ketones and usually raises dietary fat intake substantially. The lipid response is not uniform.
Across controlled trials, the most consistent pattern is a decrease in triglycerides and a modest increase in HDL cholesterol, paired with an average increase in LDL cholesterol and total cholesterol. A 2024 meta-analysis of 27 randomized trials found that ketogenic diets lowered triglycerides while raising LDL cholesterol on average. More recent pooled analyses have reached a similar conclusion: the average LDL rise is not enormous, but the range between individuals can be.
That distinction matters. If one person’s LDL-C moves from 120 to 132 mg/dL, the clinical discussion is different from someone whose LDL-C moves from 120 to 260 mg/dL. The average result from a study can hide a small group with extreme responses.
It also helps to separate cholesterol content from particle number. LDL-C estimates how much cholesterol is carried inside LDL particles. ApoB reflects the number of atherogenic lipoprotein particles, because each LDL, VLDL remnant, and similar particle carries one ApoB molecule. When LDL-C rises substantially on keto, checking ApoB testing can clarify whether the number of artery-entering particles has also increased.
The practical takeaway is simple: lower triglycerides do not cancel out a major LDL or ApoB rise. These markers describe different parts of cardiovascular risk and should be considered together.
It is also useful to distinguish a better-looking lipid ratio from a lower absolute atherogenic burden. A triglyceride-to-HDL ratio may improve dramatically on keto, but that ratio does not tell you how many LDL-family particles are circulating. For example, a person whose triglycerides fall from 220 to 90 mg/dL and HDL rises from 42 to 60 mg/dL has improved two important metabolic markers. If LDL-C simultaneously rises from 125 to 230 mg/dL and ApoB rises substantially, the overall picture is mixed rather than uniformly favorable.
Ketone levels do not solve this uncertainty. Blood beta-hydroxybutyrate can confirm nutritional ketosis, but it is not a cardiovascular risk marker. A higher ketone reading does not make a high ApoB level safer, and a lower ketone reading does not mean a diet has failed if weight, glucose, appetite, and other goals are improving. For heart-health decisions, the priority is the risk profile, not maximizing ketosis.
Why LDL Can Rise on Keto
LDL can rise for several reasons, and more than one may apply at the same time.
First, many keto diets increase saturated fat through butter, coconut oil, fatty cuts of meat, cheese, cream, and processed meats. Saturated fat can reduce LDL-receptor activity in the liver, leaving more LDL particles in circulation. People differ in how strongly they respond, but replacing saturated fat with unsaturated fat generally produces a more favorable LDL pattern. The distinction is important enough that a keto diet built around olive oil, nuts, seeds, avocado, fish, and leaner proteins can produce a very different lipid response from one centered on butter, bacon, cream, and coconut oil. For the broader evidence, see saturated fat versus unsaturated fat.
Second, rapid weight loss can temporarily change lipid movement. Fatty acids released from adipose tissue travel through the liver, and lipoprotein levels may fluctuate during active weight loss. That is one reason a mildly abnormal panel during the first few weeks should often be rechecked after weight and intake have stabilized. A very large LDL rise, however, should not be dismissed as temporary without follow-up.
Third, very low carbohydrate intake may increase LDL substantially in some lean people. This has been described as a “lean mass hyper-responder” pattern, often involving very high LDL-C, high HDL-C, and low triglycerides. The mechanism is still being studied. Importantly, low triglycerides and high HDL do not establish that very high LDL or ApoB is harmless. LDL-containing particles are directly involved in atherosclerosis, and there are not yet long-term outcome trials proving that diet-induced extreme LDL elevations are safe.
Fourth, genetics can amplify the response. Someone with familial hypercholesterolemia, a strong family history of premature heart disease, or an inherited tendency toward high LDL may see a keto diet uncover or worsen an existing problem. A sudden large increase may also prompt a clinician to check for secondary causes such as hypothyroidism, kidney disease, liver disease, or certain medications rather than blaming diet alone.
If LDL becomes markedly elevated, the right question is not “Is keto good or bad?” It is “What is driving this person’s atherogenic particle burden, and how can it be reduced?” The approach used for high LDL cholesterol still applies even if the rise began after a diet change.
Triglycerides, HDL, and Metabolic Changes
The favorable side of keto is easiest to see in people who start with insulin resistance, excess weight, high triglycerides, or high refined-carbohydrate intake.
Triglycerides often fall because carbohydrate restriction reduces the liver’s production of triglyceride-rich lipoproteins and because weight loss can improve insulin sensitivity. Meta-analyses commonly find reductions in the range of roughly 15–25 mg/dL on average, though people with very high starting values may see much larger drops. If triglycerides begin at 250 mg/dL and fall to 140 mg/dL, that is a meaningful improvement. A person starting at 90 mg/dL has much less room to improve.
HDL cholesterol often rises modestly, which is a common response to carbohydrate restriction and higher fat intake. But HDL should not be used as a protective “credit” that offsets high LDL. Modern risk assessment focuses more on the burden of ApoB-containing particles, overall risk factors, and established disease than on trying to maximize HDL.
Blood glucose, insulin, body weight, and sometimes blood pressure may also improve, especially when keto produces sustained calorie reduction and weight loss. Those benefits matter. A person with obesity and type 2 diabetes who loses 10% of body weight, improves glucose control, lowers triglycerides, and reduces blood pressure may reduce several major cardiovascular risk factors at once.
The mistake is treating that favorable pattern as proof that every marker can be ignored. Cardiovascular risk is cumulative. A person can improve insulin resistance while simultaneously worsening LDL particle burden. Both facts can be true.
If triglycerides remain high despite carbohydrate restriction, look for alcohol, excess calories, uncontrolled diabetes, hypothyroidism, medications, and genetic causes. The same fundamentals described in diet changes that lower triglycerides still matter on a low-carbohydrate diet.
What Makes a Keto Diet More or Less Heart-Friendly
“Keto” describes carbohydrate restriction, not food quality. Two diets can contain the same amount of carbohydrate and have very different effects on LDL, fiber intake, micronutrients, and long-term cardiovascular risk.
A more heart-conscious low-carbohydrate pattern emphasizes:
- Extra-virgin olive oil, avocado, nuts, and seeds as major fat sources.
- Fish and seafood regularly, especially oily fish.
- Nonstarchy vegetables at most meals.
- Protein from fish, poultry, eggs, tofu, tempeh, Greek yogurt, and selected lean meats rather than relying heavily on processed meat.
- Seeds, nuts, low-carbohydrate vegetables, and other foods that help preserve fiber intake.
- Minimal trans fat and limited use of butter, coconut oil, cream, fatty processed meats, and large quantities of high-saturated-fat cheese.
A more concerning pattern is one in which most calories come from butter coffee, bacon, sausage, processed meat, cheese, cream, coconut oil, and very little plant food. Even if ketone production is high, that pattern can be low in fiber and high in saturated fat and sodium.
Food quality also affects whether keto is sustainable. Constipation, low fiber intake, micronutrient gaps, social restriction, and difficulty maintaining the diet can cause people to cycle between strict restriction and overeating. That may produce less stable weight and metabolic control than a less extreme pattern that can be maintained for years.
For cardiovascular prevention, keto is not the only way to reduce refined carbohydrate. A Mediterranean-style lower-carbohydrate diet can retain legumes, vegetables, nuts, fish, olive oil, and modest portions of whole grains while reducing sugar and refined starch. The Mediterranean diet has much stronger long-term cardiovascular outcome evidence than a strict ketogenic diet.
What to Test and When
If you plan to follow keto for more than a short experiment, get baseline measurements before making the change whenever possible. That gives you a true comparison rather than relying on memory or a test from years earlier.
A useful baseline usually includes:
- Fasting or nonfasting lipid panel with LDL-C, HDL-C, triglycerides, total cholesterol, and non-HDL cholesterol.
- ApoB when available, especially if triglycerides are elevated, LDL is already high, or family history is concerning.
- Blood pressure.
- Weight and waist circumference.
- Fasting glucose and/or HbA1c when diabetes or prediabetes is relevant.
- Liver enzymes and kidney function when clinically appropriate.
For most people making a major dietary change, repeating lipids after about 6–12 weeks is reasonable. That is long enough for the diet to have a measurable effect and short enough to catch a major adverse response. If weight is changing rapidly, another panel after weight stabilizes can show whether the initial result persists.
ApoB is particularly helpful when LDL-C and triglycerides move in opposite directions. Non-HDL cholesterol, which is total cholesterol minus HDL cholesterol, is another simple measure of cholesterol carried by atherogenic particles.
If the result is unexpectedly high, repeat the test rather than making a major decision from one unusual value. Confirm that there was no acute illness, major change in alcohol intake, medication change, or laboratory issue. Then discuss the result in the context of age, blood pressure, smoking, diabetes, family history, kidney disease, and any known coronary disease.
How to interpret common before-and-after patterns
A modest LDL increase with a meaningful fall in triglycerides may lead to a discussion about fat quality and overall risk rather than an immediate conclusion that keto must stop. A large LDL or ApoB increase deserves more attention even when weight and glucose improve. If both LDL and triglycerides rise, look especially hard at excess calories, alcohol, uncontrolled diabetes, hypothyroidism, or a diet high in both saturated fat and refined carbohydrate during periods of inconsistent adherence.
Coronary artery calcium scanning is sometimes raised in online keto discussions as a way to decide whether very high LDL is acceptable. Calcium scoring can refine risk in selected adults, but a score of zero does not prove that years of very high ApoB are harmless. Calcium reflects established calcified plaque and is influenced strongly by age and exposure time. It should not be used as permission to ignore a severe lipid abnormality.
People with a strong family history or unexpectedly severe lipid elevation may also need evaluation for inherited disorders. An LDL-C persistently at or above about 190 mg/dL deserves clinical attention regardless of whether it appeared after starting keto.
Red Flags That Need Action
Some changes should trigger prompt reassessment rather than a “wait and see for a year” approach.
| Red flag | Why it matters | Reasonable next step |
|---|---|---|
| LDL-C rises to 190 mg/dL or higher | This level is associated with high lifetime atherosclerotic risk and can signal familial hypercholesterolemia or a strong diet response. | Repeat the test, review secondary causes, check ApoB, and discuss treatment with a clinician. |
| LDL-C roughly doubles from baseline | A large individual response can be hidden by average trial results. | Reduce saturated fat, modestly reintroduce minimally processed carbohydrates if needed, and retest. |
| ApoB becomes clearly elevated | This suggests a higher number of atherogenic particles even if triglycerides are low. | Address the particle burden rather than relying on HDL or triglycerides for reassurance. |
| Triglycerides stay at or above 500 mg/dL | Very high triglycerides raise pancreatitis risk. | Seek medical evaluation and review alcohol, diabetes control, medications, and genetic causes. |
| Chest pressure, new shortness of breath, fainting, or stroke-like symptoms | These may represent an acute cardiovascular problem, not a diet side effect to troubleshoot at home. | Seek urgent or emergency care. |
People with established coronary artery disease, prior heart attack or stroke, familial hypercholesterolemia, severe kidney disease, pregnancy, or complex diabetes medication regimens should not assume that a strict ketogenic diet is appropriate without individualized medical guidance. Keto can also increase the risk of hypoglycemia or medication-related complications when glucose-lowering drugs are not adjusted appropriately.
How to Lower Risk Without Abandoning Every Low-Carb Goal
If keto improves your weight, glucose, or appetite but LDL rises too much, you do not always have to choose between staying exactly as you are and abandoning every low-carbohydrate habit. A stepwise adjustment often works.
Start by changing the fat sources. Replace butter, coconut oil, cream, fatty red meat, and processed meats with olive oil, avocado, nuts, seeds, fish, and leaner protein. That single change can reduce saturated fat substantially without increasing carbohydrate.
Next, add soluble fiber where it fits. Psyllium, chia, flax, avocado, low-carbohydrate vegetables, and small portions of legumes for people who can tolerate them may help. A dedicated soluble fiber strategy can lower LDL without requiring a high-carbohydrate diet.
If LDL remains very high, consider moving from strict keto to a moderate low-carbohydrate pattern. Reintroducing foods such as beans, lentils, berries, intact whole grains, or unsweetened yogurt can make room for more fiber and less saturated fat while still avoiding refined carbohydrates and added sugar. Some people with dramatic LDL responses see a large improvement after modest carbohydrate reintroduction.
Then retest after about 6–12 weeks. Use the data, not the diet label, to decide what to do next.
If LDL-C or ApoB remains high despite dietary changes, discuss evidence-based lipid-lowering treatment. Statins, ezetimibe, bempedoic acid, and PCSK9-targeting therapies may be appropriate depending on risk. A preference for low-carbohydrate eating does not make atherosclerotic risk disappear, and medication should not be dismissed solely because the high LDL is diet-associated.
The most useful standard is a diet that improves the overall risk profile and can be sustained. Weight loss, glucose control, triglycerides, blood pressure, LDL-C, ApoB, food quality, and personal adherence all deserve a place in that decision.
References
- The Impact of the Ketogenic Diet on the Lipid Profile in Adults: A Comprehensive Review and Meta-Regression Analysis of Randomized Controlled Trials 2026 (Meta-Analysis)
- Effects of ketogenic diet on health outcomes: an umbrella review of meta-analyses of randomized clinical trials 2023 (Umbrella Review)
- Impact of the ketogenic diet as a dietary approach on cardiovascular disease risk factors: a meta-analysis of randomized clinical trials 2024 (Meta-Analysis)
- Ketogenic diet and cardiovascular risk – state of the art review 2024 (Review)
- Ketogenic Diets and Low-Density Lipoprotein Cholesterol in Adults With Normal Weight: An Emerging Clinical Challenge 2026 (Review)
Disclaimer
This article is for general educational purposes and is not a substitute for personalized medical advice. People with known cardiovascular disease, very high LDL cholesterol, diabetes treated with medication, kidney disease, pregnancy, or other complex medical conditions should discuss a ketogenic diet and any medication changes with a qualified clinician.
